Top 10 Leading Molecular Diagnostics Companies to Watch in 2022
Molecular diagnostics has undergone a rapid change in the last decade or more. It involves taking the DNA and RNA, a unique genetic code found in our cells, and analyzing the specific sequences that could potentially point towards disease emergence. Integrating high-intensity complex tests and new technology into the clinical molecular diagnostics laboratory has been crucial in advancing precision medicine.
From its humble beginnings in the 1930s to the first steps to the origins of gene technology in the 1970s to the age of genomics in the late 1980s and early 1990s, there has been a paradigm shift in molecular diagnostics.
The way forward is the analysis of biological markers in the genome and proteome, how their cells showcase their genes as proteins and applying molecular biology to medical testing. With specific analysis and testing, molecular diagnostics offers the scope of personalized medicine.
Molecular diagnostics covers different fields such as oncology, infectious diseases, pharma co genomics, and genetics; however, potential errors are common in different applications. Several molecular diagnostics companies continue investing heavily in new technologies to detect the
problems and implement solutions to rectify the errors and provide a better diagnosis.
The molecular diagnostics market was valued at approx. USD 53 billion in 2021 and is expected to witness around -4% CAGR between 2022 to 2028 due to the increasing geriatric population, epidemics, and much more globally. Increasing R&D activities by several prominent market players will hopefully boost the business during the forecast period.
Today, companies have a better understanding of the changes in the DNA sequence and RNA analysis that will give a better understanding of various diseases with better molecular diagnostics instruments. With this edition on molecular diagnosis and advancements in new equipment to test blood samples and derive better results, we aim to provide our readers with an overview of the technological advancement in this field.
Genome research and genetic testing are the future of medical prognosis, and there is no looking back. With a deeper understanding of how diseases develop and spread, laboratories and diagnostic companies are leveraging the knowledge to adopt the best way to help every individual in the long run.
We hope you enjoy reading our special segment on Molecular Diagnostics and get a deeper understanding of where the future lies.
.png)
Applied Biocode
Chris Bernard - CEO
Applied BioCode focuses on the research and development, manufacturing, and commercialization of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications. The HQ of the company is at Los Angles, California.
Bio-Rad Laboratories
Norman David Schwartz - CEO
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
.jpg)
Genmark
Ms. Tanya Monga - CEO
GenMark Diagnostics is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care.
genomic health
Kimberly J Popovits - CEO
Genomic Health was a company focusing on genetic research specifically in cancer detection, based out of Redwood City, California. The company was acquired by and merged with Exact Sciences Corporation in 2019.
HTG
John L. Lubniewski - CEO
HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.
Invitae
Sean George - CEO
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix.
.png)
Meridian Bioscience
Jack Kenny - CEO
Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic and life science products.
MYRAID Dignostics
Paul J. Diaz - CEO
Myriad discovers and commercializes genetic tests that determine the risk of developing the disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs.
.png)
Quest Diagnostics
Steve Rusckowski - CEO
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Sysmex Corporation
Hisashi Ietsugu - CEO
Sysmex Corporation is a Japanese company headquartered in Kobe that is engaged in the health care business. Originally called TOA Medical Electronics, the Sysmex brand was established in 1978, and were mainly involved with haematology analysers.
